EPISODE · Jan 31, 2023 · 32 MIN
Season 5: Episode 2- Seeking Clarity – Biomarkers, Diagnosis and Dementia
from Dementia Dialogue · host dementiadialogue
In this second episode on biomarkers, Ann Bil, a woman living with dementia, and Kristi Wijnsma, her daughter, discuss why they enrolled in the IMPACT-AD, their experience, and how they used the results from the investigation. Khushbu Patel, a research associate of Dr. Mari DeMarco, the principal investigator, talks about some other participants' experiences and resources available at www.impactad.org/resources.Kristi mentions the help provided through First Link, a service of the Alzheimer Society of British Columbia and other Alzheimer Societies in Canada. The analysis offered by Dr. DeMarco’s lab at St.Paul’s Hospital in Vancouver is available in Canada to consulting physicians, e.g., neurologists, geriatricians, and psychiatrists, who have patients with symptoms of dementia and may benefit from the test. It is not a screening test for people without symptoms. A presentation by Dr. Demarco on what a biomarker is at https://www.impactad.org/post/2020-alzheimer-update. For additional resources, please visit the Resource page on the Dementia Dialogue website (https://www.dementiadialogue.ca/resources-1) and choose Biomarkers from the left navigation panel. This episode is sponsored by Roche Canada.
What this episode covers
In this second episode on biomarkers, Ann Bil, a woman living with dementia, and Kristi Wijnsma, her daughter, discuss why they enrolled in the IMPACT-AD, their experience, and how they used the results from the investigation. Khushbu Patel, a research associate of Dr. Mari DeMarco, the principal investigator, talks about some other participants' experiences and resources available at www.impactad.org/resources.Kristi mentions the help provided through First Link, a service of the Alzheimer Society of British Columbia and other Alzheimer Societies in Canada. The analysis offered by Dr. DeMarco’s lab at St.Paul’s Hospital in Vancouver is available in Canada to consulting physicians, e.g., neurologists, geriatricians, and psychiatrists, who have patients with symptoms of dementia and may benefit from the test. It is not a screening test for people without symptoms. A presentation by Dr. Demarco on what a biomarker is at https://www.impactad.org/post/2020-alzheimer-update. For additional resources, please visit the Resource page on the Dementia Dialogue website (https://www.dementiadialogue.ca/resources-1) and choose Biomarkers from the left navigation panel. This episode is sponsored by Roche Canada.
NOW PLAYING
Season 5: Episode 2- Seeking Clarity – Biomarkers, Diagnosis and Dementia
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.